Clinical Trial

Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema

Name: Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema — clinical trial record (NCT07338227)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

This study aimed to validate the use of clara cell secretory protein (CC16) as a biomarker for differentiating between cardiogenic pulmonary edema (CPE) and non-cardiogenic pulmonary edema (NCPE).

Trial Details

NCT Number	NCT07338227
Lead Sponsor	Beni-Suef University
Conditions	Clara Cell Protein, Diagnostic Biomarker, Differentiation, Cardiogenic Pulmonary Edema, Non-Cardiogenic Pulmonary Edema
Enrollment	100 participants
Start Date	2023-01-01
Primary Completion	2024-01-01 (estimated)
Study Completion	2024-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-13